Pramlintide
Pramlintide (Symlin) is the heavily engineered, synthetic master-analog of human amylin. Operating as an elite, FDA-approved adjunctive therapy, it is injected alongside insulin to perfectly recreate the body’s natural bi-hormonal response to feeding. Serving as the direct biochemical forerunner to the highly anticipated Cagrilintide, it is the ultimate tool for crushing post-meal blood sugar spikes in extreme diabetic cases.
Quick Stats
Scientific Data
Mechanism of Action
Pramlintide (Symlin®) is a synthetic analog of human amylin — a pancreatic beta-cell hormone co-secreted with insulin that regulates postprandial glucose by three mechanisms: (1) slowing gastric emptying, (2) suppressing postprandial glucagon secretion from pancreatic alpha cells, and (3) promoting satiety via central amylin receptor signaling. While native amylin aggregates (causing the amyloid deposits seen in T2D), pramlintide uses proline substitutions to prevent aggregation. FDA-approved as an adjunct to insulin in both T1D and T2D, producing HbA1c reductions of 0.5-0.7% and modest weight loss (1-2 kg).
Source: FDA Label (Symlin), PMID: 15677783
Dosing Protocol
| Typical Dose | 15-120 mcg per meal |
| Frequency | 3× daily (before meals) |
| Half-Life | ~48 minutes |
| Common Vial Sizes | 0.6 mg, 1 mg |
Dosing Protocols
T2D Protocol
T1D Protocol
Administration
Expected Timeline
Who Is It For?
T1D / T2D on Insulin
HighFDA-approved with both T1D and T2D insulin regimens. Reduces postprandial spikes without extra insulin.
Postprandial Glucose Spikes
HighDirect amylin mechanism slows gastric emptying and suppresses glucagon — complementary to insulin action.
Reconstitution Example
Safety & Considerations
FDA-approved (Symlin). CRITICAL: Reduce concomitant meal-related insulin by ≥50% to prevent severe hypoglycemia. Do not mix with insulin in same syringe. Nausea is common initially — start low and titrate.
Regulatory & Legal Status
Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.
Research Chemical
US Compounding: Not eligible / not available
⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.
Dosing Quick Reference
Frequently Asked Questions
Can pramlintide be mixed with insulin in the same syringe?▼
Why do I need to reduce my insulin when starting pramlintide?▼
References
- Edelman SV et al. “"Pramlintide as an adjunct to insulin therapy in T1D and T2D".” Diabetes Technology & Therapeutics (2006). PMID: 16734556
Looking for a trusted source? See our recommended suppliers →
Independently tested · COA-verified · Save 10% with our exclusive code